Financing translation: Analysis of the NCATS rare-diseases portfolio
The portfolio of the National Center for Advancing Translational Sciences (NCATS) rare-diseases therapeutic development program comprises 28 research projects initiated at the preclinical stage. Historical data reveal substantially lower costs and higher success rates but longer preclinical timeline...
Main Authors: | , , , |
---|---|
Other Authors: | , , , |
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS),
2015-10-26T16:46:38Z.
|
Subjects: | |
Online Access: | Get fulltext |